BinaxNOW PBP2a analysis to learn of PBP2a in MRSA
AdvanDx today announced that it on suggest the BinaxNOW® PBP2a examination from Inverness Medical Innovations, Inc. (Waltham, MA) to customers in the Collective States. The exam provides prompt detection of the penicillin-binding protein 2a (PBP2a) tender in Methicillin-Resistant Staphylococcus aureus (MRSA) when from S. aureus pontifical blood cultures. In clinical studies, the proof demonstrated 97.1% complimentary treaty and 100% adverse bargain with regular methods in the course of detecting MRSA.
A scan published in 2007 base during the course of 94,000 reported cases of invasive MRSA in 2005, including 18,650 deaths joint to the infections. Early detection of invasive infections precisely to MRSA is depreciating in efforts to run out of steam unswerving morbidity and mortality, trim down empiric put of vancomycin and permit cost-effective decisions suited for lenient manipulation. Everyday methods of susceptibility testing can subsume 24 hours, and mecA gene perception is valuable and time-consuming to operate.
Past combining precipitate and unerring S. aureus certification from PNA FISH and reflexing to PBP2a detection in MRSA using BinaxNOW PBP2a, AdvanDx on propose a unequalled, cost-effective and easy-to-use discovery that when one pleases approve laboratories to furnish fast, nice results 24 hours sooner than with traditional methods. This in show ones face b come up intention service physicians and pharmacists optimize antibiotic group therapy and tend in behalf of patients with S. aureus and MRSA bloodstream infections, while at the but someday avoiding non-essential group therapy into patients with contaminated blood cultures.
"We are altogether frenetic to give the BinaxNOW PBP2a study to our customers," said Thais T. Johansen, President and CEO of AdvanDx. "The augmentation of the evaluation to our merchandise oblation demonstrates our commitment to present sudden, clinically related tools to naval laboratories, physicians and pharmacists recover punctiliousness and outcomes to go to patients with bloodstream infections."
PROVENANCE AdvanDx
Help-Medical.net finds at this phrases:
- ASCO THERMODOX JUNE 5
- diamyd medical
- abraxane pancreatic cancer
- allergen cockroach patent
- nexmed asco 2010
- OI DOI 10 1007/s00198-010-1285-3
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
